Yinxingmihuan
Chronic Stable Angina
China National Center for Cardiovascular DiseasesN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
18 Active assets in the Chronic Stable Angina cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid Rajaie Cardiovascular Medical and Research Center | Phase 4 | BBB |
Ezetimibe Canadian Collaborative Research Network | Phase 4 | BBB |
Ranolazine OBS Pakistan | Phase 4 | BBB |
SIMVASTATIN University of Washington | Phase 4 | BBB |
Rivaroxaban Sheffield Teaching Hospitals NHS Foundation Trust | Phase 4 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →